Low-Dose Dexmedetomidine Bolus With Propofol for Pediatric MRI: Faster Recovery, More Bradycardia
This single-center randomized trial tests a 0.5 µg/kg dexmedetomidine bolus as a propofol-sparing adjunct for pediatric magnetic resonance imaging (MRI) sedation, a practical question for pharmacists who prepare, dilute and monitor these regimens outside the operating room.
Dexmedetomidine as an adjunct shortens MRI sedation recovery in children.
Sedation for pediatric MRI must balance efficacy with safety, minimizing drug-related complications. Dexmedetomidine and propofol reduced recovery time to 19.4 minutes and required less propofol compared to propofol alone, with increased bradycardia risk. The study suggests potential practice changes in pediatric sedation for MRI but is limited by the increased bradycardia risk and study-specific protocol. Dexmedetomidine can enhance pediatric MRI sedation with faster recovery but monitor for bradycardia.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Dhanaboopathy K, Rai E, Williams A, Jose R, Rebekah G, Joselyn AS
Citation:Dhanaboopathy K, Rai E, Williams A, et al. Efficacy of dexmedetomidine as an adjuvant to propofol-based total intravenous anesthesia in children undergoing magnetic resonance imaging: A prospective randomized controlled trial. Journal of anaesthesiology, clinical pharmacology. 2026;42(4):572-577. doi:10.4103/joacp.joacp_557_25